Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference
February 04 2020 - 6:00AM
Summit Therapeutics plc (‘Summit’ or the
‘Company’)
Summit Therapeutics to Present at the 2020 BIO CEO &
Investor Conference
Oxford, UK, and Cambridge, MA, US, 4 February
2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM)
announces that Mr Glyn Edwards, Chief Executive Officer, will
present at the 2020 BIO CEO & Investor Conference on 10
February 2020 at 2:15pm EST in New York City.
A live webcast of the presentation will be
available in the Investors section of the Company's website,
www.summitplc.com. A replay of the webcast will be available from
the same location soon after the live presentation.
About Summit Therapeutics Summit
Therapeutics is a leader in antibiotic innovation. Our new
mechanism antibiotics are designed to become the new standards of
care for the benefit of patients and create value for payors and
healthcare providers. We are currently developing new mechanism
antibiotics for infections caused by C. difficile,
Enterobacteriaceae and N. gonorrhoeae and are using our proprietary
Discuva Platform to expand our pipeline. For more information,
visit www.summitplc.com and follow us on Twitter @summitplc.
Contacts
Summit |
|
|
Glyn Edwards / Richard Pye (UK office) |
Tel: |
44 (0)1235 443 951 |
Michelle Avery (US office) |
|
+1 617 225 4455 |
|
|
|
Cairn Financial Advisers LLP (Nominated Adviser) |
Tel: |
+44 (0)20 7213 0880 |
Liam Murray / Tony Rawlinson / Ludovico Lazzaretti |
|
|
|
|
|
N+1 Singer (Joint Broker) |
Tel: |
+44 (0)20 7496 3000 |
Aubrey Powell / George Tzimas, Corporate FinanceTom Salvesen,
Corporate Broking |
|
|
|
|
|
Bryan Garnier & Co Limited (Joint Broker) |
Tel: |
+44 (0)20 7332 2500 |
Phil Walker / Dominic Wilson |
|
|
MSL Group (US) |
Tel: |
+1 781 684 6552 |
Erin Anthoine |
|
summit@mslgroup.com |
|
|
|
Consilium Strategic Communications (UK) |
Tel: |
+44 (0)20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Sukaina Virji |
|
summit@consilium-comms.com |
Lindsey Neville |
|
|
-END-
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jul 2023 to Jul 2024